2006
DOI: 10.1016/j.nurx.2006.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Growth factors and stroke

Abstract: Summary: Current options for the treatment of stroke are extremely limited, partly because of the rapidity with which brain cells die when deprived of their blood supply. Several recent studies suggest that growth factors can produce improvement in animal models of stroke, even when administered at postischemic intervals of many hours to days, when conventional neuroprotective approaches are typically futile.Several growth factors can access the brain after systemic administration, making them more attractive … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
22
0
1

Year Published

2008
2008
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(23 citation statements)
references
References 62 publications
0
22
0
1
Order By: Relevance
“…This finding of a neurovascular niche for neurogenesis after stroke is supported by the many growth factors or pharmacological agents that appear capable of inducing both of these processes together, such as VEGF, erythropoietin, FGF2, statins and phosphodieseterase type 5 inhibitors. [75][76][77][78] These data linking angiogenic blood vessels with newly born immature neurons in peri-infarct cortex appear at odds with the reported association of immature neurons and astrocytes in the ischemic striatum. 69 As reviewed below, the differences in association of newly born immature neurons in stroke predominantly with astrocytes in ischemic striatum and with angiogenic blood vessels in peri-infarct cortex likely relates to important, and often overlooked, differences in the stroke models used in neural repair studies.…”
Section: Poststroke Neurogenesismentioning
confidence: 97%
“…This finding of a neurovascular niche for neurogenesis after stroke is supported by the many growth factors or pharmacological agents that appear capable of inducing both of these processes together, such as VEGF, erythropoietin, FGF2, statins and phosphodieseterase type 5 inhibitors. [75][76][77][78] These data linking angiogenic blood vessels with newly born immature neurons in peri-infarct cortex appear at odds with the reported association of immature neurons and astrocytes in the ischemic striatum. 69 As reviewed below, the differences in association of newly born immature neurons in stroke predominantly with astrocytes in ischemic striatum and with angiogenic blood vessels in peri-infarct cortex likely relates to important, and often overlooked, differences in the stroke models used in neural repair studies.…”
Section: Poststroke Neurogenesismentioning
confidence: 97%
“…Neural stem cells enact cell proliferation and recruitment through the production and secretion of growth factors that are correlated with recovery following ischemia, including endothelial growth factor (EGF) and FGF-2 (Greenberg and Jin, 2006;Vishwakarma et al, 2014). Some growth factors such as VEGF have a short-term impact, having demonstrated an increase in vascularity of infarcted tissue following stroke (Greenberg and Jin, 2006), and presenting upregulation in rat middle cerebral artery occlusion (MCAO) models after 3 h (Marti et al, 2000).…”
Section: Goal Of Tissue Engineering Strategiesmentioning
confidence: 99%
“…Some growth factors such as VEGF have a short-term impact, having demonstrated an increase in vascularity of infarcted tissue following stroke (Greenberg and Jin, 2006), and presenting upregulation in rat middle cerebral artery occlusion (MCAO) models after 3 h (Marti et al, 2000). Both insulin-growth factor-1 (IGF-1) and BDNF have also demonstrated promising results as acute therapies, beginning administration after 30 and 15 min post MCAO, respectively, and primarily attributed to reduction in infarct volume (Greenberg and Jin, 2006). Growth factor presentation in various forms is integral to promoting repair and functional recovery following stroke.…”
Section: Goal Of Tissue Engineering Strategiesmentioning
confidence: 99%
“…Поэтому ростовые факторы и металлопротеина-зы, продуцируемые макрофагами, нейронами, астроцитами, олигодендроцитами и эндотели-альными клетками, обеспечивают процессы вос-становления и ремоделирования поврежденной нервной ткани [15,40].…”
Section: адаптивный иммунный ответunclassified